Search results for "Adverse Events"
Outcomes similar with one or two weeks of antibiotics for gram-negative bacteremia
Although 90-day mortality and readmission rates were not affected by shorter therapy, neither were rates of adverse events such as Clostridium difficile infection.
https://acphospitalist.acponline.org/weekly/archives/2018/12/19/1.htm
19 Dec 2018
New warnings against mixing opioids and benzos
Details on the latest recalls, warnings, and approvals.
https://acphospitalist.acponline.org/archives/2016/11/fda.htm
15 Nov 2016
Central lines, IV solutions, test strips recalled
Details on the latest recalls, warnings, and approvals.
https://acphospitalist.acponline.org/archives/2016/04/fda.htm
15 Apr 2016
January 2016
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2016/01/
Warning on risk of hacking with cardiac devices
Details on the latest warnings, recalls, and approvals.
https://acphospitalist.acponline.org/archives/2017/03/fda.htm
15 Mar 2017
Latest COVID-19 research on dexamethasone, hydroxychloroquine, vaccines, tocilizumab
Peer-reviewed details on the recent trial of dexamethasone were released, and two new trials found no benefit to early treatment with hydroxychloroquine. Positive data from three vaccine trials were also published, as was another study of tocilizumab.
https://acphospitalist.acponline.org/weekly/archives/2020/07/22/1.htm
22 Jul 2020
Latest COVID-19 research looks at plasma, prophylaxis, palliative care, periop risks
The benefit of convalescent plasma is uncertain, and hydroxychloroquine did not appear to work for prophylaxis, according to new studies. Experts offered advice on using palliative care, avoiding surgery, changing residency applications, and understanding antibody testing.
https://acphospitalist.acponline.org/weekly/archives/2020/06/10/1.htm
10 Jun 2020
High-intensity medical therapy at HF discharge reduced readmissions, death
Researchers stopped the STRONG-HF randomized trial early due to greater than expected differences in outcomes between patients who received rapid up-titration of guideline-directed medical therapy under strict follow-up and those who received usual care.
https://acphospitalist.acponline.org/archives/2022/11/16/high-intensity-medical-therapy-at-hf-discharge-reduced-readmissions-death.htm
16 Nov 2022
Bedside sitters, pneumothorax, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/07/in-the-news.htm
15 Jul 2020
For PE in critically ill, half-dose alteplase associated with more treatment escalation than full dose
Mortality and bleeding rates were similar whether critically ill patients with pulmonary embolism (PE) received 50 mg or 100 mg of alteplase, the retrospective study found.
https://acphospitalist.acponline.org/weekly/archives/2018/07/18/5.htm
18 Jul 2018